LEADER 01670nam0 2200373 i 450 
001 SUN0124569
005 20191022111810.66
010   $d0.00
017 70$2N$a978-3-030-00641-9
100   $a20191021d2018       |0engc50      ba
101   $aeng
102   $aCH
105   $a||||    |||||
200 1 $aAn *Introduction to the Language of Mathematics$fFrédéric Mynard
205   $aCham : Springer, 2018
210   $axii$d185 p.$cill. ; 24 cm
215   $aPubblicazione in formato elettronico
606   $a11Axx$xElementary number theory [MSC 2020]$2MF$3SUNC019694
606   $a03E25$xAxiom of choice and related propositions [MSC 2020]$2MF$3SUNC020025
606   $a06A06$xPartial order, general [MSC 2020]$2MF$3SUNC022498
606   $a11A51$xFactorization; primality [MSC 2020]$2MF$3SUNC023242
606   $a03E20$xOther classical set theory (including functions, relations, and set algebra) [MSC 2020]$2MF$3SUNC024408
606   $a03Bxx$xGeneral logic [MSC 2020]$2MF$3SUNC024425
606   $a03F07$xStructure of proofs [MSC 2020]$2MF$3SUNC031517
606   $a97Exx$xEducation of foundations of mathematics [MSC 2020]$2MF$3SUNC034147
620   $aCH$dCham$3SUNL001889
700  1$aMynard$b, Frédéric$3SUNV057364$0732154
712   $aSpringer$3SUNV000178$4650
801   $aIT$bSOL$c20210503$gRICA
856 4 $uhttp://doi.org/10.1007/978-3-030-00641-9
912   $aSUN0124569
950   $aUFFICIO DI BIBLIOTECA DEL DIPARTIMENTO DI MATEMATICA E FISICA$d08CONS      e-book                  1031        $e08eMF1031              20191021            
996   $aIntroduction to the Language of Mathematics$91564654
997   $aUNICAMPANIA

LEADER 02217nam  2200577   450 
001 9910827838803321
005 20230803021102.0
010   $a1-78084-270-8
010   $a1-78084-271-6
035   $a(CKB)2550000001101935
035   $a(EBL)1179645
035   $a(OCoLC)854971660
035   $a(SSID)ssj0001599928
035   $a(PQKBManifestationID)16306258
035   $a(PQKBTitleCode)TC0001599928
035   $a(PQKBWorkID)14892839
035   $a(PQKB)11287715
035   $a(MiAaPQ)EBC1179645
035   $a(Au-PeEL)EBL1179645
035   $a(EXLCZ)992550000001101935
100   $a20220517d2013      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aEmerging therapeutic options for hepatitis C /$feditors, Masao Omata, Tatsuo Kanda
205   $a1st ed.
210  1$aLondon, England :$cFuture Medicine Ltd.,$d[2013]
210  4$d©2013
215   $a1 online resource (117 p.)
300   $aDescription based upon print version of record.
311   $a1-78084-272-4 
327   $aTitle page; Copyright page; Contents; Foreword. Hepatitis C virus infection: from discovery to eradication; 1. Interferons in clinical trials; 2. Protease inhibitors; 3. NS5A inhibitor: daclatasvir; 4. Toll-like receptor agonists for nonresponders to hepatitis C virus treatment: hope versus promise?; 5. Treatment options in HIV-HCV-coinfected patients; 6. Treatment options for dual hepatitis C/hepatitis B virus coinfection; 7. Hepatitis C virus treatment in patients with metabolic syndrome; 8. Future directions in hepatitis C therapy; Index
330   $aEmerging Therapeutic Options for Hepatitis C
606   $aHepatitis C$xTreatment
606   $aHepatitis C$xChemotherapy
606   $aAntiviral agents
615  0$aHepatitis C$xTreatment.
615  0$aHepatitis C$xChemotherapy.
615  0$aAntiviral agents.
676   $a616.362306
702   $aOmata$b Masao
702   $aKanda$b Tatsuo
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910827838803321
996   $aEmerging therapeutic options for hepatitis C$94007384
997   $aUNINA